{"id":"https://openalex.org/W4394603296","doi":"https://doi.org/10.1158/2767-9764.25569250.v1","title":"Supplementary Figure 2 from Inhibition of NEK2 Promotes Chemosensitivity and Reduces KSHV-positive Primary Effusion Lymphoma Burden","display_name":"Supplementary Figure 2 from Inhibition of NEK2 Promotes Chemosensitivity and Reduces KSHV-positive Primary Effusion Lymphoma Burden","publication_year":2024,"publication_date":"2024-04-09","ids":{"openalex":"https://openalex.org/W4394603296","doi":"https://doi.org/10.1158/2767-9764.25569250.v1"},"language":"en","primary_location":{"id":"doi:10.1158/2767-9764.25569250.v1","doi":"https://doi.org/10.1158/2767-9764.25569250.v1","is_oa":true,"landing_page_url":"https://doi.org/10.1158/2767-9764.25569250.v1","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"volume":null,"type":"supplementary-materials","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.1158/2767-9764.25569250.v1","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5082271001","display_name":"Maria C. White","orcid":"https://orcid.org/0000-0002-9410-1798","observed_orcids":["https://orcid.org/0000-0002-9410-1798"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Maria C. White","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-9410-1798","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5020565504","display_name":"Jason P. Wong","orcid":"https://orcid.org/0000-0002-0710-3112","observed_orcids":["https://orcid.org/0000-0002-0710-3112"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jason P. Wong","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-0710-3112","affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5021245679","display_name":"Blossom Damania","orcid":"https://orcid.org/0000-0002-9205-1774","observed_orcids":["https://orcid.org/0000-0002-9205-1774"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Blossom Damania","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-9205-1774","affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10685","display_name":"Viral-associated cancers and disorders","score":0.9907000064849854,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10685","display_name":"Viral-associated cancers and disorders","score":0.9907000064849854,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10492","display_name":"Microtubule and mitosis dynamics","score":0.00419999985024333,"subfield":{"id":"https://openalex.org/subfields/1307","display_name":"Cell Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.0005000000237487257,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/kaposi-s-sarcoma-associated-herpesvirus","display_name":"Kaposi's sarcoma-associated herpesvirus","score":0.8679999709129333},{"id":"https://openalex.org/keywords/primary-effusion-lymphoma","display_name":"primary effusion lymphoma","score":0.9419999718666077},{"id":"https://openalex.org/keywords/viral-reactivation","display_name":"viral reactivation","score":0.8640000224113464},{"id":"https://openalex.org/keywords/orf45","display_name":"ORF45","score":0.8330000042915344},{"id":"https://openalex.org/keywords/sirna-knockdown","display_name":"siRNA knockdown","score":0.7540000081062317},{"id":"https://openalex.org/keywords/chemosensitivity","display_name":"chemosensitivity","score":0.8629999756813049}],"concepts":[{"id":"https://openalex.org/C2779594685","wikidata":"https://www.wikidata.org/wiki/Q3832899","display_name":"Primary effusion lymphoma","level":3,"score":0.9323669075965881},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.4538598358631134},{"id":"https://openalex.org/C2779338263","wikidata":"https://www.wikidata.org/wiki/Q208414","display_name":"Lymphoma","level":2,"score":0.4313836991786957},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.39240598678588867},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.3544723391532898},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.33618247509002686}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.1158/2767-9764.25569250.v1","doi":"https://doi.org/10.1158/2767-9764.25569250.v1","is_oa":true,"landing_page_url":"https://doi.org/10.1158/2767-9764.25569250.v1","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},{"id":"pmh:oai:figshare.com:article/25569250","doi":null,"is_oa":true,"landing_page_url":"https://figshare.com/articles/journal_contribution/Supplementary_Figure_2_from_Inhibition_of_NEK2_Promotes_Chemosensitivity_and_Reduces_KSHV-positive_Primary_Effusion_Lymphoma_Burden/25569250","pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"Text"}],"best_oa_location":{"id":"doi:10.1158/2767-9764.25569250.v1","doi":"https://doi.org/10.1158/2767-9764.25569250.v1","is_oa":true,"landing_page_url":"https://doi.org/10.1158/2767-9764.25569250.v1","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9391000270843506,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4394602508","https://openalex.org/W4394603231","https://openalex.org/W4394603222","https://openalex.org/W4394602747","https://openalex.org/W4394602989","https://openalex.org/W4394603742","https://openalex.org/W4394603647","https://openalex.org/W4362535307","https://openalex.org/W4393092864","https://openalex.org/W2013191622"],"abstract_inverted_index":{"Figure":[0],"S2.":[1],"NEK2":[2,95,104,109,143,148],"inhibition":[3],"does":[4],"not":[5],"induce":[6],"reactivation":[7],"of":[8,16,68,79,123,134,186,197],"KSHV.":[9],"(A)":[10],"Fold":[11,129],"change":[12,39,130,161],"in":[13,20,74,89,99,131,138,192,207],"gene":[14,132],"expression":[15,105,110,133,144,149],"KSHV":[17,97,135],"lytic":[18,136],"genes":[19,137],"PEL":[21,100,139],"cells":[22,50,101,140,172],"treated":[23,52],"with":[24,53,58,76,102,141,176,194],"or":[25,107,146],"without":[26],"JH295":[27],"for":[28,61,94,179],"48h.":[29,62,180],"Data":[30,63,120,152,181],"were":[31,51,153,173],"normalized":[32,154],"to":[33,41,155,163],"actin":[34,156],"and":[35,55,96,157],"plotted":[36,158],"as":[37,116,159],"fold":[38,160],"relative":[40,162],"the":[42,46,77,80,117,164,167,195,198],"DMSO":[43,54],"control.":[44,119],"For":[45,166],"positive":[47,81,168,199],"control,":[48,82,169,200],"BCBL1":[49,171],"chemically":[56,174],"reactivated":[57,175],"valproic":[59,177],"acid":[60,178],"represent":[64,182],"mean":[65,183],"\u00b1":[66,184],"SEM":[67,185],"two":[69,124,187],"biological":[70,86,126,188,204],"replicates,":[71,189],"each":[72,190],"performed":[73,88,191,206],"triplicate,":[75,193],"exception":[78,196],"which":[83,201],"is":[84,202],"one":[85,203],"replicate":[87,205],"triplicate.":[90,208],"(B)":[91],"Western":[92],"blot":[93],"ORF45":[98],"intact":[103,142],"(NTC)":[106,145],"depleted":[108,147],"(NEK2":[111,150],"siRNA).":[112,151],"GAPDH":[113],"was":[114],"used":[115],"loading":[118],"are":[121],"representative":[122],"independent":[125],"replicates.":[127],"(C)":[128],"NTC.":[165],"NTC-treated":[170]},"counts_by_year":[],"updated_date":"2026-09-02T18:50:13.731487","created_date":"2024-04-10T00:00:00"}